← Back
$SGHT All transactions

Sight Sciences, Inc.

▲ BUY
6 / 10

Conviction

$ Value

$94K

Shares

26,715

Price

$4

Filed

May 29

Why this score? (6/10)
  • Open market buy (+3)
  • Director (+1)
  • 10%+ owner (+1)
  • Not a 10b5-1 plan (+1)

Insider

Name

Encrantz Staffan

Title

CIK

0001870875

Roles

Director 10% Owner

Transaction Details

Transaction Date

2025-05-28

Code

P

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,097,577

Footnotes

The price reported in Column 4 is a weighted average price. These shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), were purchased in multiple transactions at per share prices ranging from $3.29 to $3.46 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $3.325 to $3.60 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | The price reported in Column 4 is a weighted average price. These shares of Common Stock were purchased in multiple transactions at per share prices ranging from $3.50 to $3.71 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. | Includes (i) 1,140,339 shares of Common Stock and (ii) 17,366 restricted stock units, which are subject to vesting as previously reported. | These shares of Common Stock are held of record by the 1997 Staffan Encrantz and Margareta Encrantz Revocable Trust (the "Trust"). The Reporting Person is a trustee of the Trust and may be deemed to beneficially own the shares held by the Trust for purposes of Rule 13d-3 under the Securities Exchange Act of 1934 (the "Exchange Act"). The Reporting Person disclaims beneficial ownership of the shares held by the Trust (and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 under the Exchange Act or for any other purpose), except to the extent of his pecuniary interest therein, if any. | These shares of Common Stock are held of record by Allegro Investment Fund, L.P. ("Allegro Investment Fund"). The Reporting Person is the President and sole director of Allegro Investment Inc., which is the investment manager of Allegro Investment Fund, and may be deemed to beneficially own the shares held by Allegro Investment Fund for purposes of Rule 13d-3 under the Exchange Act. However, the Reporting Person does not have any pecuniary interest in the shares held by Allegro Investment Fund and disclaims beneficial ownership with respect to all such shares. Accordingly, these shares are being reported in this report voluntarily by the Reporting Person for informational purposes only and shall not be deemed an admission that the Reporting Person is the beneficial owner of any such shares for purposes of Section 16 under the Exchange Act or for any other purpose.

Filing Info

Accession No.

0000950170-25-079292

Form Type

4

Issuer CIK

0001531177

Encrantz Staffan's History

Date Ticker Type Value
2025-12-16 SGHT $116K
2025-06-06 SGHT $118K
2025-06-05 SGHT $174K
2025-06-05 SGHT A $0
2025-06-04 SGHT $90K
2025-06-03 SGHT $100K
2025-06-02 SGHT $119K
2025-05-30 SGHT $157K
2025-05-29 SGHT $216K
2025-05-28 SGHT $94K

Other Insiders at SGHT (90d)

Insider Bought Sold Last
Bauerlein Alison
Chief Operating Officer
$90K 2026-04-02
Taylor Brenton
EVP, Operations & R&D
$11K 2026-04-01
HAYDEN JEREMY B.
Chief Legal Officer
$49K 2026-04-06
Badawi David
Chief Technology Officer
$28K 2026-04-02
Badawi Paul
President and CEO
$108K 2026-04-01
Rodberg James
Chief Financial Officer
$26K 2026-04-06